<PAGE>

    As filed with the Securities and Exchange Commission on February 1, 2002
================================================================================
                                                         Registration No. 333-**

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   ----------

                                    FORM S-8
                             REGISTRATION STATEMENT
                                      Under
                           THE SECURITIES ACT OF 1933

                                   ----------

                              PHARMACIA CORPORATION
               (Exact name of company as specified in its charter)

                    Delaware                            43-0420020
        (State or Other Jurisdiction of     (I.R.S. Employer Identification No.)
        Incorporation or Organization)


                  100 Route 206 North
                     Peapack, NJ                              07977
       (Address of principal executive offices)             (Zip Code)


                              Pharmacia Corporation
                          2001 Long-Term Incentive Plan
                            (Full title of the plan)

                             Don W. Schmitz, Esquire
        Vice President, Associate General Counsel and Corporate Secretary
                              Pharmacia Corporation
                               100 Route 206 North
                                Peapack, NJ 07977
                     (Name and address of agent for service)

                                  908-901-8000
          (Telephone number, including area code, of agent for service)

                                   ----------

                         Copy of all communications to:
                             Robert J. Lichtenstein
                           Morgan, Lewis & Bockius LLP
                               1701 Market Street
                      Philadelphia, Pennsylvania 19103-2921
                                 (215) 963-5000

                         CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>

==================================================================================================================================

                                                           Proposed maximum           Proposed maximum
    Title of securities            Amount to be             Offering price               Aggregate                 Amount of
     to be registered             Registered (1)             per share (2)           Offering price (2)       registration fee (3)
----------------------------------------------------------------------------------------------------------------------------------
<S>                                 <C>                         <C>                    <C>                        <C>
  Pharmacia Common Stock            55,000,000                  $39.54                 $2,174,700,000             $200,072.40
==================================================================================================================================
</TABLE>
(1)      This Registration Statement covers 55,000,000 shares of the
         Registrant's Common Stock which may be offered or sold pursuant to the
         Pharmacia Corporation 2001 Long-Term Incentive Plan. This Registration
         Statement also relates to an indeterminate number of shares of Common
         Stock of the Registrant which may be issued upon stock splits, stock
         dividends, or similar transactions in accordance with Rule 416.
(2)      Estimated pursuant to Rule 457(c) and (h) solely for the purpose of
         calculating the registration fee, based upon the average high and low
         January 28, 2002 sales prices of the Registrant's Common Stock on the
         New York Stock Exchange.
(3)      The registration fee of $200,072.40 was wired from the Company on
         February 1, 2002.

================================================================================

<PAGE>

                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.       Incorporation of Documents by Reference.
              ---------------------------------------

              The following documents filed with the U.S. Securities and
Exchange Commission (the "Commission") by Pharmacia Corporation (the "Company")
pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), are incorporated by reference in this Form S-8 Registration Statement
(the "Registration Statement") and made a part hereof:

              1. The  Company's  Annual  Report on Form 10-K for the year  ended
December 31, 2000 (the "2000 10-K"); and

              2. The Company's Quarterly Reports on Form 10-Q for the quarterly
periods ended March 31, 2001, June 30, 2001, and September 30, 2001.

              3. The Company's Current Reports on Form 8-K filed on February 1,
2001, June 22, 2001, and September 20, 2001.

              4. The description of the Common Stock of the Registrant contained
in the Registration Statement on Form S-4, which was filed with the Commission
on February 22, 2000, including any amendment thereto or report filed for the
purpose of updating such description.

              All documents and reports filed by the Company pursuant to Section
13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this
Registration Statement and prior to the filing of a post-effective amendment
which indicates that all securities offered hereby have been sold or which
deregisters all securities then remaining unsold shall be deemed to be
incorporated by reference herein and to be a part hereof from the date of filing
of such documents or reports. Any statement contained in a document incorporated
or deemed to be incorporated by reference herein shall be deemed to be modified
or superseded for purposes of this Registration Statement to the extent that a
statement contained herein or in any other subsequently filed document which
also is or is deemed to be incorporated by reference herein modifies or
supersedes such statement. Any such statement so modified shall not be deemed to
constitute a part of the Registration Statement except as so modified and any
statement so superseded shall not be deemed to constitute a part of this
Registration Statement.

Item 4.       Description of Securities.
              -------------------------

              Not Applicable

Item 5.       Interests of Named Experts and Counsel.
              --------------------------------------

              Not Applicable


<PAGE>

Item 6.       Indemnification of Directors and Officers.
              -----------------------------------------

              Section 145 of the Delaware General Corporation Law authorizes a
court to award, or a corporation's board of directors to grant, indemnity to
directors and officers in terms sufficiently broad to permit such
indemnification under certain circumstances for liabilities (including
reimbursement for expenses incurred) arising under the Securities Act of 1933
(the "Securities Act"). The Company's Certificate of Incorporation and By-laws
provide for indemnification of its directors, officers, employees and other
agents to the maximum extent permitted by the Delaware General Corporation Law.
In addition, the Company has entered into Indemnification Agreements with its
executive officers and directors. The Company has also purchased and maintained
insurance for its officers, directors, employees or agents against liabilities
which an officer, a director, an employee or an agent may incur in his capacity
as such.

Item 7.       Exemption from Registration Claimed.
              -----------------------------------

              Not Applicable

Item 8.       Exhibits.
              --------
<TABLE>
<CAPTION>

Exhibit Numbers                                       Exhibit
---------------      --------------------------------------------------------------------------
<S>                    <C>
      4              Certificate  of  Incorporation  and  By-laws  of  Pharmacia   Corporation
                     (incorporated by reference to the Registrant's  Registration Statement on
                     Form S-4 filed with the Commission on February 22, 2000.)
      5              Opinion of Counsel
      5.1            Consent of Counsel (incorporated by reference to Exhibit 5)
     23.1            Consent of PricewaterhouseCoopers LLP
     23.2            Consent of Deloitte & Touche LLP
     99              Pharmacia Corporation 2001 Long-Term Incentive Plan
</TABLE>

Item 9.       Undertakings.
              ------------

              The undersigned hereby undertakes:

                    (1) To file, during any period in which offers or sales are
              being made, a post-effective amendment to this Registration
              Statement:

                           (i) To include any prospectus required by Section
                           10(a)(3) of the Securities Act;

                           (ii) To reflect in the prospectus any facts or events
                           arising after the effective date of the Registration
                           Statement (or the most recent post-effective
                           amendment thereof) which, individually or in the
                           aggregate, represent a fundamental change in the
                           information set forth in the Registration Statement;
                           and

                           (iii) To include any material information with
                           respect to the plan of distribution not previously
                           disclosed in the Registration Statement or any
                           material change to such information in the
                           Registration Statement;

              provided, however, that subparagraphs (a)(1)(i) and (a)(1)(ii) of
              this section do not apply if the information required to be
              included in a post-effective amendment by those subparagraphs is
              contained in periodic reports filed with or furnished to the
              Commission by the Registrant pursuant to Section 13 or Section
              15(d) of the Exchange Act that are incorporated by reference in
              the Registration Statement.


<PAGE>

                    (2) That, for the purpose of determining any liability under
              the Securities Act, each such post-effective amendment shall be
              deemed to be a new registration statement relating to the
              securities offered therein, and the offering of such securities at
              that time shall be deemed to be the initial bona fide offering
              thereof; and

                    (3) To remove from registration by means of a post-effective
              amendment any of the securities being registered that remain
              unsold at the termination of the offering.

              The undersigned company hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the Company's
annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act
that is incorporated by reference in this Registration Statement shall be deemed
to be a new Registration Statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.

              Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons
of the Company pursuant to the foregoing provisions, or otherwise, the Company
has been advised that in the opinion of the Commission such indemnification is
against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Company of expenses incurred or paid
by a director, officer or controlling person of the Company in the successful
defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the
Company will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as
expressed in the Securities Act and will be governed by the final adjudication
of such issue.


<PAGE>


                                   SIGNATURES

         Pursuant to the requirements of the Securities Act of 1933, the Company
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the State of New Jersey on January 31, 2002.

                                PHARMACIA CORPORATION

                                By:   /s/ Fred Hassan
                                      ------------------
                                Name:    Fred Hassan
                                Title:   Chairman and Chief Executive Officer


                  Pursuant to the requirements of the Securities Act of 1933,
this Registration Statement or amendment thereto has been signed below as of the
31 day of January, 2002 by or on behalf of the following persons in the
capacities indicated below.

                                Power of Attorney

KNOW ALL MEN BY THESE PRESENTS that each person whose signature appears below
constitutes and appoints Don W. Schmitz, attorney for him or her and in his or
her name and on his or her behalf to sign the Registration Statement on Form
S-8, and any amendments thereto, of Pharmacia Corporation to be filed with the
Securities and Exchange Commission under the Securities Act of 1933, with
respect to the issue and sale of shares of Common Stock of Pharmacia Corporation
pursuant to the provisions of the Pharmacia Corporation 2001 Long-Term Incentive
Plan, and generally to do and perform all things necessary to be done in the
premises as fully and effectually in all respects as I could do if personally
present.


Signature                                            Title


/s/ Fred Hassan                                  Chairman and Chief
-------------------------------------            Executive Officer
Fred Hassan                                      (Principal Executive Officer)

/s/ Christopher J. Coughlin                      Executive Vice President
------------------------------------             and Chief Financial Officer
Christopher J. Coughlin                          (Principal Financial Officer)





<PAGE>

/s/ Robert G. Thompson                           Senior Vice President
------------------------------------             and Controller (Principal
Robert G. Thompson                               Accounting Officer)


/s/ Frank C. Carlucci                            Director
------------------------------------
Frank C. Carlucci


/s/ M. Kathryn Eickhoff                          Director
------------------------------------
M. Kathryn Eickhoff


/s/ Michael Kantor                               Director
------------------------------------
Michael Kantor


/s/ Gwendolyn S. King                            Director
------------------------------------
Gwendolyn S. King


/s/ Philip Leder, MD                             Director
------------------------------------
Philip Leder, MD


/s/ R.L. Berthold Lindqvist                      Director
------------------------------------
R.L. Berthold Lindqvist


/s/ Olof G. Lund                                 Director
------------------------------------
Olof G. Lund


/s/ C. Steven McMillan                           Director
------------------------------------
C. Steven McMillan


/s/ William U. Parfet                            Director
------------------------------------
William U. Parfet


/s/ Jacobus F.M. Peters                          Director
------------------------------------
Jacobus F.M. Peters



<PAGE>


/s/ Ulla B. Reinius                              Director
------------------------------------
Ulla B. Reinius


/s/ William D. Ruckelshaus                       Director
------------------------------------
William D. Ruckelshaus


/s/ Bengt I. Samuelsson                          Director
------------------------------------
Bengt I. Samuelsson







<PAGE>

                                INDEX TO EXHIBITS

<TABLE>
<CAPTION>

Exhibit Numbers                                       Exhibit
---------------      --------------------------------------------------------------------------
<S>                      <C>
      4              Certificate of Incorporation and By-laws of Pharmacia Corporation
                     (incorporated by reference to the Registrant's Registration Statement on
                     Form S-4 filed with the Commission on February 22, 2000.)
      5              Opinion of Counsel
      5.1            Consent of Counsel (incorporated by reference to Exhibit 5)
     23.1            Consent of PricewaterhouseCoopers LLP
     23.2            Consent of Deloitte & Touche LLP
     99              Pharmacia Corporation 2001 Long-Term Incentive Plan

</TABLE>
[{"type": "S-8", "sequence": "1", "filename": "s-8.txt", "secsgml_size_bytes": 17632}]
{"company-data": {"conformed-name": "PHARMACIA CORP /DE/", "cik": "0000067686", "assigned-sic": "2800", "irs-number": "430420020", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-82002", "film-number": "02525441"}, "business-address": {"street1": "100 ROUTE 206 NORTH", "city": "PEAPACK", "state": "NJ", "zip": "07977", "phone": "9089018000"}, "mail-address": {"street1": "100 ROUTE 206 NORTH", "city": "PEAPACK", "state": "NJ", "zip": "07977"}, "former-company": [{"former-conformed-name": "MONSANTO CHEMICAL CO", "date-changed": "19711003"}, {"former-conformed-name": "MONSANTO CO", "date-changed": "19920703"}]}
As filed with the Securities and Exchange Commission on February 1, 2002
================================================================================
                                                         Registration No. 333-**

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   ----------

                                    FORM S-8
                             REGISTRATION STATEMENT
                                      Under
                           THE SECURITIES ACT OF 1933

                                   ----------

                              PHARMACIA CORPORATION
               (Exact name of company as specified in its charter)

                    Delaware                            43-0420020
        (State or Other Jurisdiction of     (I.R.S. Employer Identification No.)
        Incorporation or Organization)

                  100 Route 206 North
                     Peapack, NJ                              07977
       (Address of principal executive offices)             (Zip Code)

                              Pharmacia Corporation
                          2001 Long-Term Incentive Plan
                            (Full title of the plan)

                             Don W. Schmitz, Esquire
        Vice President, Associate General Counsel and Corporate Secretary
                              Pharmacia Corporation
                               100 Route 206 North
                                Peapack, NJ 07977
                     (Name and address of agent for service)

                                  908-901-8000
          (Telephone number, including area code, of agent for service)

                                   ----------

                         Copy of all communications to:
                             Robert J. Lichtenstein
                           Morgan, Lewis & Bockius LLP
                               1701 Market Street
                      Philadelphia, Pennsylvania 19103-2921
                                 (215) 963-5000

                         CALCULATION OF REGISTRATION FEE
==================================================================================================================================

                                                           Proposed maximum           Proposed maximum
    Title of securities            Amount to be             Offering price               Aggregate                 Amount of
     to be registered             Registered (1)             per share (2)           Offering price (2)       registration fee (3)
----------------------------------------------------------------------------------------------------------------------------------
Pharmacia Common Stock            55,000,000                  $39.54                 $2,174,700,000             $200,072.40
==================================================================================================================================
(1)      This Registration Statement covers 55,000,000 shares of the
         Registrant's Common Stock which may be offered or sold pursuant to the
         Pharmacia Corporation 2001 Long-Term Incentive Plan. This Registration
         Statement also relates to an indeterminate number of shares of Common
         Stock of the Registrant which may be issued upon stock splits, stock
         dividends, or similar transactions in accordance with Rule 416.
(2)      Estimated pursuant to Rule 457(c) and (h) solely for the purpose of
         calculating the registration fee, based upon the average high and low
         January 28, 2002 sales prices of the Registrant's Common Stock on the
         New York Stock Exchange.
(3)      The registration fee of $200,072.40 was wired from the Company on
         February 1, 2002.

================================================================================
PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.       Incorporation of Documents by Reference.
              ---------------------------------------

              The following documents filed with the U.S. Securities and
Exchange Commission (the "Commission") by Pharmacia Corporation (the "Company")
pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), are incorporated by reference in this Form S-8 Registration Statement
(the "Registration Statement") and made a part hereof:

              1. The  Company's  Annual  Report on Form 10-K for the year  ended
December 31, 2000 (the "2000 10-K"); and

              2. The Company's Quarterly Reports on Form 10-Q for the quarterly
periods ended March 31, 2001, June 30, 2001, and September 30, 2001.

              3. The Company's Current Reports on Form 8-K filed on February 1,
2001, June 22, 2001, and September 20, 2001.

              4. The description of the Common Stock of the Registrant contained
in the Registration Statement on Form S-4, which was filed with the Commission
on February 22, 2000, including any amendment thereto or report filed for the
purpose of updating such description.

              All documents and reports filed by the Company pursuant to Section
13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this
Registration Statement and prior to the filing of a post-effective amendment
which indicates that all securities offered hereby have been sold or which
deregisters all securities then remaining unsold shall be deemed to be
incorporated by reference herein and to be a part hereof from the date of filing
of such documents or reports. Any statement contained in a document incorporated
or deemed to be incorporated by reference herein shall be deemed to be modified
or superseded for purposes of this Registration Statement to the extent that a
statement contained herein or in any other subsequently filed document which
also is or is deemed to be incorporated by reference herein modifies or
supersedes such statement. Any such statement so modified shall not be deemed to
constitute a part of the Registration Statement except as so modified and any
statement so superseded shall not be deemed to constitute a part of this
Registration Statement.

Item 4.       Description of Securities.
              -------------------------

              Not Applicable

Item 5.       Interests of Named Experts and Counsel.
              --------------------------------------

              Not Applicable
Item 6.       Indemnification of Directors and Officers.
              -----------------------------------------

              Section 145 of the Delaware General Corporation Law authorizes a
court to award, or a corporation's board of directors to grant, indemnity to
directors and officers in terms sufficiently broad to permit such
indemnification under certain circumstances for liabilities (including
reimbursement for expenses incurred) arising under the Securities Act of 1933
(the "Securities Act"). The Company's Certificate of Incorporation and By-laws
provide for indemnification of its directors, officers, employees and other
agents to the maximum extent permitted by the Delaware General Corporation Law.
In addition, the Company has entered into Indemnification Agreements with its
executive officers and directors. The Company has also purchased and maintained
insurance for its officers, directors, employees or agents against liabilities
which an officer, a director, an employee or an agent may incur in his capacity
as such.

Item 7.       Exemption from Registration Claimed.
              -----------------------------------

              Not Applicable

Item 8.       Exhibits.
              --------
Exhibit Numbers                                       Exhibit
---------------      --------------------------------------------------------------------------
4              Certificate  of  Incorporation  and  By-laws  of  Pharmacia   Corporation
                     (incorporated by reference to the Registrant's  Registration Statement on
                     Form S-4 filed with the Commission on February 22, 2000.)
      5              Opinion of Counsel
      5.1            Consent of Counsel (incorporated by reference to Exhibit 5)
     23.1            Consent of PricewaterhouseCoopers LLP
     23.2            Consent of Deloitte & Touche LLP
     99              Pharmacia Corporation 2001 Long-Term Incentive Plan
Item 9.       Undertakings.
              ------------

              The undersigned hereby undertakes:

                    (1) To file, during any period in which offers or sales are
              being made, a post-effective amendment to this Registration
              Statement:

                           (i) To include any prospectus required by Section
                           10(a)(3) of the Securities Act;

                           (ii) To reflect in the prospectus any facts or events
                           arising after the effective date of the Registration
                           Statement (or the most recent post-effective
                           amendment thereof) which, individually or in the
                           aggregate, represent a fundamental change in the
                           information set forth in the Registration Statement;
                           and

                           (iii) To include any material information with
                           respect to the plan of distribution not previously
                           disclosed in the Registration Statement or any
                           material change to such information in the
                           Registration Statement;

              provided, however, that subparagraphs (a)(1)(i) and (a)(1)(ii) of
              this section do not apply if the information required to be
              included in a post-effective amendment by those subparagraphs is
              contained in periodic reports filed with or furnished to the
              Commission by the Registrant pursuant to Section 13 or Section
              15(d) of the Exchange Act that are incorporated by reference in
              the Registration Statement.
(2) That, for the purpose of determining any liability under
              the Securities Act, each such post-effective amendment shall be
              deemed to be a new registration statement relating to the
              securities offered therein, and the offering of such securities at
              that time shall be deemed to be the initial bona fide offering
              thereof; and

                    (3) To remove from registration by means of a post-effective
              amendment any of the securities being registered that remain
              unsold at the termination of the offering.

              The undersigned company hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the Company's
annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act
that is incorporated by reference in this Registration Statement shall be deemed
to be a new Registration Statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.

              Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons
of the Company pursuant to the foregoing provisions, or otherwise, the Company
has been advised that in the opinion of the Commission such indemnification is
against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Company of expenses incurred or paid
by a director, officer or controlling person of the Company in the successful
defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the
Company will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as
expressed in the Securities Act and will be governed by the final adjudication
of such issue.
SIGNATURES

         Pursuant to the requirements of the Securities Act of 1933, the Company
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the State of New Jersey on January 31, 2002.

                                PHARMACIA CORPORATION

                                By:   /s/ Fred Hassan
                                      ------------------
                                Name:    Fred Hassan
                                Title:   Chairman and Chief Executive Officer

                  Pursuant to the requirements of the Securities Act of 1933,
this Registration Statement or amendment thereto has been signed below as of the
31 day of January, 2002 by or on behalf of the following persons in the
capacities indicated below.

                                Power of Attorney

KNOW ALL MEN BY THESE PRESENTS that each person whose signature appears below
constitutes and appoints Don W. Schmitz, attorney for him or her and in his or
her name and on his or her behalf to sign the Registration Statement on Form
S-8, and any amendments thereto, of Pharmacia Corporation to be filed with the
Securities and Exchange Commission under the Securities Act of 1933, with
respect to the issue and sale of shares of Common Stock of Pharmacia Corporation
pursuant to the provisions of the Pharmacia Corporation 2001 Long-Term Incentive
Plan, and generally to do and perform all things necessary to be done in the
premises as fully and effectually in all respects as I could do if personally
present.

Signature                                            Title

/s/ Fred Hassan                                  Chairman and Chief
-------------------------------------            Executive Officer
Fred Hassan                                      (Principal Executive Officer)

/s/ Christopher J. Coughlin                      Executive Vice President
------------------------------------             and Chief Financial Officer
Christopher J. Coughlin                          (Principal Financial Officer)
/s/ Robert G. Thompson                           Senior Vice President
------------------------------------             and Controller (Principal
Robert G. Thompson                               Accounting Officer)

/s/ Frank C. Carlucci                            Director
------------------------------------
Frank C. Carlucci

/s/ M. Kathryn Eickhoff                          Director
------------------------------------
M. Kathryn Eickhoff

/s/ Michael Kantor                               Director
------------------------------------
Michael Kantor

/s/ Gwendolyn S. King                            Director
------------------------------------
Gwendolyn S. King

/s/ Philip Leder, MD                             Director
------------------------------------
Philip Leder, MD

/s/ R.L. Berthold Lindqvist                      Director
------------------------------------
R.L. Berthold Lindqvist

/s/ Olof G. Lund                                 Director
------------------------------------
Olof G. Lund

/s/ C. Steven McMillan                           Director
------------------------------------
C. Steven McMillan

/s/ William U. Parfet                            Director
------------------------------------
William U. Parfet

/s/ Jacobus F.M. Peters                          Director
------------------------------------
Jacobus F.M. Peters
/s/ Ulla B. Reinius                              Director
------------------------------------
Ulla B. Reinius

/s/ William D. Ruckelshaus                       Director
------------------------------------
William D. Ruckelshaus

/s/ Bengt I. Samuelsson                          Director
------------------------------------
Bengt I. Samuelsson
INDEX TO EXHIBITS
Exhibit Numbers                                       Exhibit
---------------      --------------------------------------------------------------------------
4              Certificate of Incorporation and By-laws of Pharmacia Corporation
                     (incorporated by reference to the Registrant's Registration Statement on
                     Form S-4 filed with the Commission on February 22, 2000.)
      5              Opinion of Counsel
      5.1            Consent of Counsel (incorporated by reference to Exhibit 5)
     23.1            Consent of PricewaterhouseCoopers LLP
     23.2            Consent of Deloitte & Touche LLP
     99              Pharmacia Corporation 2001 Long-Term Incentive Plan